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Purpose: The purpose of this study was to evaluate feasibility and safety of endovascular stent grafting for the treatment
of patients with rupture of the descending thoracic aorta.
Methods: Thirteen patients with rupture of the descending thoracic aorta were treated with endovascular stent grafting.
Six patients were treated on the day of diagnosis because their vital signs were unstable, and the other seven patients were
treated electively. Five patients had infection or potential infection, and the other eight patients did not. Expanded
polytetrafluoroethylene-covered or polyester-covered Z stents were used in all patients.
Results: Stent grafts were successfully placed in all patients. No endoleaks were observed at the end of the procedure.
However, rebleeding was observed within 2 weeks of the procedure in two patients with infection. Six patients (46%) died
within 5 months of the procedure (mean survival period, 61 60 days). All five patients with infection (100%) died, and
only one of eight patients without infection (13%) died (P < .01). The remaining seven patients are alive during the mean
follow-up period of 21 months (overall survival rate, 54%), although additional surgical interventions, including surgical
conversion in one case and upper extremity extraanatomic bypass in the other, were necessary in two of these patients.
Conclusion: Endovascular stent grafting may be a safe and feasible method for the treatment of rupture of the descending
thoracic aorta in selected patients without infection. However, its usefulness in terms of long-term prognosis appears to
be extremely limited, especially in patients with infection. (J Vasc Surg 2003;37:100-5.)
Endoluminal stent graft placement has now become
widespread in the treatment of almost all aortic diseases after
its initial clinical application in the early 1990s.1,2 One of the
advantages of interventional procedures over conventional
open surgery is that the lesion can be accessed with less risk of
further bleeding. Since the initial introduction of this technol-
ogy in the clinical setting, aortic rupture has been one of the
most reasonable and potentially beneficial indications of en-
dovascular technology because of this advantage.3 Recently,
several investigators have reported the effectiveness of stent
grafting for the treatment of aortic rupture. However, the
numbers of treated patients have been small and no consensus
can be reached on whether this technology is superior to
conventional surgical repair in terms of long-term out-
come.4-8 In this report, we describe our experience in the use
of endovascular stent grafting in the treatment of patients with
rupture of the descending thoracic aorta and discuss the
prognosis of patients after such therapy.
METHODS
Patients. Between July 1997 and February 2002, 71
patients with descending aortic diseases were treated with
endovascular stent graft placement. Among them, 13 pa-
tients (18%) had rupture of the descending thoracic aorta.
There were 10 men and three women. The ages ranged
from 16 years to 82 years (mean, 65  17 years). Conven-
tional surgical repair was judged inadvisable because of
various coexisting problems in all patients (Table I).
Three patients were hypotensive (systolic blood pres-
sure 90 mm Hg at any given preoperative point). Two of
these patients with hypotension received blood transfusion
(15 units and 36 units, respectively) since hypotension was
sustained. Six patients, including three with hypotension,
underwent stent graft repair on the day of diagnosis. The
other seven patients underwent repair after a mean period
of 44  45 days (range, 1 to 110 days). Five of the 13
patients (38%) had infection or potential infection at the
rupture site (ie, active mycotic aneurysm in two patients
and fistulous communication with surrounding structures
in two patients). In one patient with ruptured thoracic
aortic aneurysm, potential fistulous communication be-
tween the aneurysm and the airway system was suspected
because of hemoptysis.
Approval was obtained from the Institutional Review
Board of the hospital. Informed consent was obtained from
each patient or from the family when the patient was
unconscious or was under age 20 years.
Preoperative imaging. Computed tomographic
(CT) scan imaging was performed before surgery in 11
patients for diagnosis, and the remaining two patients did
not undergo CT scanning but were examined with angiog-
raphy immediately after the diagnosis of rupture on the
basis of clinical findings. Calibrated angiography with a
catheter with graduations (Merit Medical Systems, South
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Jordan, Utah) was performed to determine the access
routes and landing zones in all patients. Blood flow to
aortic branches was also checked with angiography in
cases of aortic dissection. CT scan images obtained pre-
viously were used to determine the design of the stent
grafts in patients who did not undergo preoperative CT
scan.
Stent grafts. Homemade stent grafts were used in all
patients. Stent grafts were fabricated from Z stents (Cook,
Bloomington, Ind) covered with thin wall woven polyes-
ter (UBE, Tokyo, Japan), which expanded polytetrafluo-
roethylene (Impra, Tempe, Ariz) and were dilated with a
balloon catheter until the desired diameter was obtained.
When thinner delivery systems were necessary, expanded
polytetrafluoroethylene–covered stents were preferred.
Graft materials were attached to the Z stents with 5-0
polypropylene sutures (Ethicon, Somerville, NJ). The di-
ameters of the stent grafts were selected to be 10% to 20%
larger than those of both the proximal and distal landing
zones, which were measured on CT scan or angiography.
An 18F, 20F, or 22F delivery system (Cook) was used for
deployment. For patients whose hemodynamics were un-
stable, back-up stent grafts were used. At our institution,
we keep back-up stent grafts of the tubular type in four sizes
(25, 32, 36, and 40 mm in diameter and 7.5 cm in length)
for the treatment of aortic diseases.
Table I. Patient characteristics
No.
Age/
gender
Symptoms
and signs Disease
Coexisting
problems
(Potential)
Infection
Hypo-
tension
Blood
transfusion
before/
during
stent
grafting
Hemo-
globin
(g/Dl)
ASA
score
Interval
between
rupture
and
treatment
(d)
1 75/Male Back pain Type B aortic
dissection with
rupture
Chronic renal
failure, aortic
regurgitation
No No N/A 7.5 III 0
2 64/Female None Traumatic pseudo-
aneurysm of
thoracic aorta
Multiple fracture,
hemothorax
No No N/A 12.1 II 30
3 59/Male Massive he-
matemesis
Fistula between
thoracic aorta
and esophagus
Esophageal
carcinoma
Yes Yes 36 units 5.3 IV 0
4 82/Female Chest pain,
hemoptysis
Rupture of my-
cotic aneurysm
of thoracic aorta
Bacteremia Yes No N/A 8 III 0
5 63/Male Hemoptysis Rupture of true
aneurysm of
thoracic aorta
History of left up-
per lobectomy
and radiation
therapy
Yes No N/A 8.8 III 71
6 75/Male Back pain Type B aortic dis-
section with
rupture
Hemothorax No Yes N/A 6.8 III 0
7 16/Male None Traumatic pseudo-
aneurysm of
thoracic aorta
Multiple fracture,
urethral rup-
ture, contusion
of small bowel
mensentery
No No N/A 11 III 115
8 59/Male Massive he-
matemesis
Fistula between
thoracic aorta
and ileum
History of esopha-
geal resection
Yes Yes 18 units 6.7 IV 0
9 79/Male Hoarseness,
left shoulder
pain
Rupture of true
aneurysm of
thoracic aorta
History of left
thoracoplasty
No No N/A 11.1 III 88
10 70/Male Back pain Type A aortic
dissection with
rupture
Hemomediastinum No No N/A 9.4 III 0
11 64/Male None Traumatic pseudo-
aneurysm of
thoracic aorta
Multiple fracture,
hemothorax,
liver laceration,
asthma
No No N/A 9.2 III 1
12 70/Female Back pain Rupture of my-
cotic aneurysm
of thoracic aorta
Liver cirrhosis Yes No N/A 6.4 III 7
13 77/Male Back pain Rupture of true
aneurysm of
thoracic aorta
History of left
thoracoplasty
No No N/A 9.8 III 3
N/A, Not applicable; ASA, American Society of Anesthesiologists.
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Procedures. Stent graft placement was performed
with general anesthesia. After femoral arteriotomy, the
delivery system was advanced until its tip reached the
proximal landing zone. The stent graft was inserted and
advanced into the delivery system. Stent grafts were de-
ployed by quickly withdrawing the outer sheath while
firmly grasping the pusher mandrel. The blood pressure
was reduced with a vasodilator, or transient cardiac arrest
with adenosine was used to avoid misplacement. In one
patient (patient 5), extraanatomic bypass surgery was nec-
essary between the ascending aorta and the cervical
branches under side clamping of the ascending aorta to
create a sufficiently long proximal landing zone before stent
graft placement. Antibiotics were administered from the
time of initial diagnosis and were continued indefinitely in
all patients with infection or potential infection.
Follow-up. Follow-up examination was performed
with CT scan at 1 week, 1 month, 3 months, 6 months, and
Fig 1. A 77-year-old man with contained rupture of middle descending thoracic aorta. Because patient had history of
left thoracoplasty, stent graft repair was chosen. After stent graft repair, patient followed favorable clinical course
without any complications. A, Angiography before (left) and after (right) stent graft placement. Aneurysm was
completely excluded after stent grafting. B, CT scan before (left) and at 1 week after (right) stent grafting. Aneurysm
has completely excluded after stent grafting.
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1 year and yearly thereafter. Endoscopic examination was
performed in a patient with rebleeding (patients 4 and 8).
Statistical analysis. Comparison of survival and com-
plication rates was performed with the 2 test. A P value of
less than .05 was considered statistically significant.
RESULTS
Technical outcomes. Stent grafts were successfully
placed in all patients (Fig 1). Seven patients needed one
stent graft for successful repair, and six patients needed two
stent grafts for successful repair. The diameter and the
length of the stent grafts were 3.2  0.3 cm (range, 2.7 to
3.6 cm) and 8.2  1.2 cm (range, 7.5 to 10.0 cm),
respectively. Complete exclusion of the aneurysm or com-
plete sealing of the rupture site or entry tear, as confirmed
with angiography at the end of the procedure, was achieved
in all patients. All patients with hypotension became nor-
motensive after stent graft placement. Disruption of the
femoral artery at the access site occurred in one patient
being treated for traumatic pseudoaneurysm of the proxi-
mal descending aorta (patient 7). Interposition of a vascular
graft was necessary after stent graft placement in this pa-
tient. There were no other intraoperative complications.
Immediate clinical outcomes. Five of the 13 patients
(38%) died before discharge, with a mean survival rate of 52
62 days (range, 3 to 142 days; Table II). The causes of death
were related to infection in three patients who had infection or
potential infection at the rupture site before stent graft place-
ment. These included rebleeding in two patients from infec-
tious degeneration of the landing zones (patients 4 and 8) and
sepsis in the remaining patient (patient 3). The cause of death
in one patient with infection was brain stem infarction (patient
12). In this patient, fistulous communication between the
descending thoracic aorta and the esophagus was observed
during the follow-up period and was finally healed before
death (Fig 2). The other patient, who had no infection, died of
pneumonia (patient 1).
Late clinical outcomes. Eight (57%) of 13 patients
could be discharged from the hospital. Only five of the 13
patients (38%) are doing well and did not have any late
complications during the mean follow-up period of 21 
16 months (range, 4 to 47 months). However, one patient
who had a thoracic aortic aneurysm with contained rupture
and hemoptysis died of sepsis on the 106th day after stent
grafting (patient 5). The cause of sepsis was thought to be
related to infection through the communication between
the airways and the ruptured aneurysm. The remaining two
patients underwent additional interventions after dis-
charge. Aneurysmal degeneration developed at the top end
of the stent graft in the proximal descending thoracic aorta
on the 41st postoperative day in one patient who had acute
type B aortic dissection with rupture. Because the proximal
neck was not sufficiently long, this patient underwent open
surgery (patient 6). The other patient, who had acute type
A aortic dissection with rupture, had left arm numbness
after discharge (patient 10). Because the cause of this
symptom was thought to be related to occlusion of the left
subclavian artery by the stent graft, the patient underwent
bypass surgery between the two subclavian arteries.
In summary, the overall survival rate in all patients with
rupture of the descending thoracic aorta who were treated
with endovascular stent grafting was 54% (7/13). In terms
of the disease at the rupture site, all the five patients who had
infection or potential infection died, and only one of eight
patients (13%) without infection died (P .01). Aorta-related
complications, including infection, were observed in all the
five patients (100%) who had infection or potential infection,
and such complications were observed in only two of eight
patients (25%) without infection (P .01).
The general condition became stable after stent graft-
ing in three of five patients with infection (patients 3, 5, and
12) for 3 months or more. Open surgery was not indicated
for them because of their coexisting problems, including
advanced esophageal carcinoma, history of upper lobec-
Table II. Outcomes
No. Alive/dead
Stent graft–
related death
Postprocedural problems
and management
Stent graft–related
postoperative problems
Follow-up
(d)
1 Dead No Pneumonia None 9
2 Alive N/A None None 1410
3 Dead Yes Sepsis Sepsis 90
4 Dead Yes Rebleeding, resection of aneurysm
and extraanatomic bypass,
multiple organ failure
Rebleeding 3
5 Dead Yes Pneumonia, sepsis Sepsis 106
6 Alive N/A Aneurysm development, surgical
conversion
Aneurysmal degeneration 750
7 Alive N/A None None 750
8 Dead Yes Rebleeding Rebleeding 14
9 Alive N/A None None 570
10 Alive N/A Left arm ischemia, bypass surgery Left arm ischemia 540
11 Alive N/A Respiratory failure None 360
12 Dead No Fistulous communication between
aorta and esophagus, brain stem
infarction
Fistulous communication between
aorta and esophagus
150
13 Alive N/A None None 120
N/A, Not applicable.
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tomy of the left lung and radiation therapy, and severe liver
cirrhosis. However, they might have undergone definitive
surgery if they had not had such serious problems.
DISCUSSION
Semba et al4 treated 11 patients with contained rupture
of the descending thoracic aorta. Complete exclusion of the
rupture was achieved in all patients without any procedure-
related complications. In addition, they achieved an overall
survival rate of 80%, which is much higher than that for
surgical intervention, although it was not clarified whether
there was infection at the rupture site in their series. Several
investigators have reported similar results for the endovas-
cular treatment of traumatic aortic pseudoaneurysms.5,6
Similar to their rates, the overall survival rate of patients
without infection, including traumatic pseudoaneurysm
and aortic dissection with rupture, was 88% in our series.
This fact is not surprising because stent graft repair is much
less invasive than open surgery.
Controversy still exists concerning the appropriate treat-
ment of mycotic aneurysms (ie, extraanatomic bypass with
aneurysm excision versus in situ graft replacement).9,10 How-
ever, the latter seems to have gained favor because mortality
and morbidity rates for the two methods are similar but the
former suffers from several limitations. Taylor et al9 treated
five patients with infected abdominal aortic aneurysms with
extraanatomic bypass, aneurysm excision, and drainage. There
were no operative deaths or complications except for wound
dehiscence in one patient in their series.9 Chan et al10 treated
22 patients with mycotic aortic aneurysms, including mycotic
thoracic aortic aneurysms, with in situ prosthetic graft replace-
ment and showed an early survival rate of 86%.
As an alternative, Semba et al11 have adopted endovas-
cular stent grafting for the treatment of mycotic aneurysms.
Although only three patients underwent such treatment
and the follow-up period was short, exclusion of the aneu-
rysm was achieved without any complications. In our series,
five patients had infection or potential infection. In contrast
to the previous report, all the five patients died within 5
months of stent graft repair. The causes of death were
related to the infection at the rupture site in all patients
except for one. In addition, rebleeding was observed from
Fig 2. A 70-year-old woman with mycotic aneurysm in middle descending thoracic aorta. Although fistulous
communication between aorta and esophagus developed after stent grafting, which was finally healed, patient was doing
well until sudden death from brain stem infarction 5 months later. A, CT scan before (left) and after (right) stent graft
placement. Pseudoaneurysm was completely excluded after stent grafting. B, Esophagogram obtained 1 month after
stent grafting. Contrast medium can be seen in aneurysmal sac.
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the ends of the stent grafts in one patient, where the stent
grafts were exposed from infectious degeneration of the
aortic walls in the landing zone. This should be the result of
the remaining infected tissue after stent grafting, unlike the
case for in situ graft replacement, in which debridement is
performed simultaneously, even though antibiotics are ad-
ministered in both methods.10
Taking our results into consideration and comparing
them with those of surgical interventions,9,10 we may not
be able to expect too much for the endovascular treatment
of diseases in patients with infection. Instead, stent grafting
could be used as a temporizing measure before definitive
surgery. As described previously, three patients with infec-
tion would have had a chance to undergo definitive surgery
after stent grafting stabilized their general condition if they
had not had such serious coexisting problems.
There are several disadvantages in the endovascular repair
of aortic rupture. First, it is not an uncommon situation for no
stent grafts of appropriate size to be available when a patient
with free rupture needs treatment. As mentioned previously,
we keep several back-up stent grafts of the tubular type for the
treatment of aortic diseases. This is why we are able to treat
free ruptures in the emergent setting. However, it may not be
possible for all institutions to store a sufficiently wide range of
back-up stent grafts. Second, the hoop strength of stent grafts
may have adverse effects on the walls of the landing zone. The
walls of the landing zone may be fragile in cases with infection
or potential infection, and excessive hoop strength may prove
to be another factor responsible for degeneration of the walls,
leading to rebleeding. In our series, rebleeding was observed
in two patients. The main cause of rebleeding appeared to be
infectious degeneration of the walls of the landing zone.
However, the hoop strength of the stent grafts used may also
have contributed to wall degeneration. Third, the stent grafts
we use are semirigid designs that make it difficult to achieve
complete apposition to the aortic curvature. Late surgical
repair was necessary in one patient with acute type B aortic
dissection to treat aneurysmal degeneration, which developed
at the proximal end of the stent graft. In this case, the cause of
aneurysmal degeneration was thought to be related to me-
chanical interference between the fragile intimal flap and the
edge of the stent graft.12
Endovascular stent grafting for the treatment of the
ruptured descending thoracic aorta appears to be feasible in
some patients and may prove to be useful because of its
reduced invasiveness in carefully selected patients (ie, those
without infection). However, its efficacy in the treatment of
ruptures with infection or potential infection appears to be
extremely limited, and it may not contribute to long-term
survival. Secondary definitive intervention, including com-
bined resection of the rupture site and extraanatomic by-
pass surgery or debridement and in situ graft replacement,
may be necessary after stabilization of the patient’s condi-
tion to improve long-term survival.
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